This week's View focuses again on the COVID-19 resources on ACC.org, featuring key points to remember from three articles: a perspective on how patients with ST-segment elevation myocardial infarction should be managed during the COVID-19 pandemic, a viewpoint on COVID-19 and renin angiotensin blockers, and a review on the current state of diagnostic testing for COVID-19 infections.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, COVID-19 Hub, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, ACS and Cardiac Biomarkers, Lipid Metabolism, Novel Agents, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and ACS, Interventions and Imaging, Angiography, Computed Tomography, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, Acute Coronary Syndrome, Angiotensin II, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antibody Formation, Biomarkers, Pharmacological, Blood Pressure, Coronary Angiography, Coronavirus, Coronavirus Infections, COVID-19, C-Reactive Protein, Delivery of Health Care, Diagnostic Imaging, Emergency Service, Hospital, Fibrinolytic Agents, Heart Failure, Hypertension, L-Lactate Dehydrogenase, Lung Injury, Metabolic Syndrome, Myocardial Infarction, Myocardial Reperfusion, Pandemics, Peptidyl-Dipeptidase A, Percutaneous Coronary Intervention, Primary Prevention, Renin, Renin-Angiotensin System, Reperfusion, Respiratory System, SARS Virus, Secondary Prevention, Severe Acute Respiratory Syndrome, severe acute respiratory syndrome coronavirus 2, Thrombolytic Therapy, Tomography, X-Ray Computed, Vascular Diseases, Dyslipidemias, ACC COVID-19 Podcast

< Back to Listings